PathoGenetix Raises $4M in First Closing of Series B Financing

The company, formerly called US Genomics, will use the funding to complete development of its system for identifying pathogens in complex biological samples, which is scheduled for commercial release in 2012.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.